Dow printed its first closing record in 3+ months. Oil sold off on renewed U.S.-Iran deal optimism. Bond yields eased after touching 4.69% on Tuesday. Risk-on tone across the board.
| Ticker | Close | Change | Note |
|---|---|---|---|
| AAPL | $304.99 | +0.91% | New ATH $305.54 intraday |
| ASML | $1,592 | +2.70% | UBS top pick, PT EUR1,900 |
| CRWV | $107.58 | +6.22% | $3.1B loan facility, bounce off $100 |
| NVDA | $219.51 | -1.77% | Post-earnings sell-the-news |
| TSM | $407.15 | +1.38% | — |
| AMZN | $268.46 | +1.30% | — |
| META | $607.38 | +0.38% | — |
| MSFT | $419.09 | -0.47% | — |
| TSLA | $417.85 | +0.14% | SpaceX S-1 filed |
| AVGO | $414.57 | -0.76% | — |
| GOOGL | $387.66 | -0.32% | — |
NVDA closed at $219.51, down 1.77% despite crushing Q1 ($81.6B revenue, +85% YoY, $91B Q2 guide). Classic sell-the-news. Intraday range $217.93-$227.40.
Analyst PT upgrades post-earnings:
Consensus PT now ~$283, implying 29% upside from today's close. Margins held steady (a key concern heading in). Vera Rubin on track H2 2026. China remains the overhang -- no H20 resolution.
UBS analyst Francois-Xavier Bouvignies raised PT to EUR1,900 (from EUR1,600) and called ASML the "most attractive risk/reward in the sector." Key thesis points:
Stock hit $1,601.79 intraday, extending its ATH run. Current consensus PT is $1,504 -- ASML is now trading 6% above consensus, but UBS's EUR1,900 (~$2,100+) implies 30%+ upside.
CoreWeave bounced 6.2% to $107.58 off the $100 psychological floor (intraday low $103.16). Catalysts: $3.1B loan facility closed, ranked #1 for inference speed in Moonshot AI's Kimi K2.6 benchmarks.
Still, insider selling (CTO Venturo, Magnetar, ARK) was heavy through May 7-8. DA Davidson downgraded to Underperform. The stock is 42% below its 52-week high of $187.
Apple printed $305.54 intraday, extending the breakout above $300 that began May 20. The rally is on momentum from Q2 FY2026 beat, $100B buyback, and demand for MacBook Neo / AI-powered devices despite TSMC 3nm supply constraints.
Not part of your semi rotation plan, but worth noting: AAPL is now the most expensive Mag 7 name on a P/E basis. If you're trimming META to fund the rotation, AAPL's strength provides a favorable risk backdrop for the broader market.
| Firm | New PT | Prior PT | Rating |
|---|---|---|---|
| HSBC | $325 | $295 | Buy |
| GF Securities | $308 | $292 | Buy |
| DA Davidson | $300 | $250 | Buy |
| KeyBanc | $300 | $275 | Overweight |
| Morgan Stanley | $285 | $260 | Overweight |
| TD Cowen | $275 | $235 | Buy |
| Aletheia | $270 | $250 | Buy |
Street consensus ~$283. At $219.51, NVDA trades at a 23% discount to the average PT and 32% below the high-water mark.
The META -> semi chain rotation plan is staring at its designed entry window. NVDA is in a textbook post-earnings dip with every major analyst raising targets. ASML just got a major institutional upgrade that reinforces the thesis. TSM is holding firm. The macro backdrop (easing yields, oil retreating, Dow at record) is supportive.
The one wrinkle: Memorial Day weekend means any Friday orders sit for three days. If you want to start sizing in, consider placing limit orders Friday morning with the awareness that news flow (Iran deal, OpenAI filing) could move things over the weekend. Alternatively, wait for Tuesday's open for a cleaner read.